Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.

Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.

Checkmate Capital Group Completes Seed Investment in Lactiga, Inc. Lactiga is pleased to announce the completion of a seed investment by Checkmate Capital Group, LLC (Pasadena, California) to provide essential financial support for continued product development,...
Lactiga accepted to the Princeton Growth Accelerator

Lactiga accepted to the Princeton Growth Accelerator

Lactiga accepted to the Princeton Growth Accelerator Lactiga joins the Princeton Growth Accelerator which provides networking, physical space, mentoring, etc. Expanding our footprint into the New Jersey biotechnology cluster is an important part of Lactiga’s...
Lactiga Announces NIH-Funded Partnership with Mount Sinai

Lactiga Announces NIH-Funded Partnership with Mount Sinai

Lactiga Announces NIH-Funded Partnership with Mount Sinai Lactiga announced today a collaboration agreement with the Icahn School of Medicine at Mount Sinai to advance preclinical research into LCTG-001 as a potential treatment for COVID-19 patients. The collaborative...
Lactiga wins the Business Innovation Award

Lactiga wins the Business Innovation Award

Lactiga wins the Business Innovation Award Lactiga was selected as the Winner in the Business Innovation category of the Small & Mighty Summit, a forum to showcase businesses in the Greater Toronto Region, in recognition of our efforts at novel therapeutics for...
Lactiga takes 2nd place in the LaunchYU Accelerator program

Lactiga takes 2nd place in the LaunchYU Accelerator program

Lactiga takes 2nd place in the LaunchYU Accelerator program Lactiga won the 2nd-place prize of $10,000 in York University’s LaunchYU Accelerator program this year. Innovation York’s LaunchYU Accelerator program supports entrepreneurs through dedicated workshops with...